Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
277.4 USD | +1.26% | +1.41% | -3.69% |
01/05 | Amgen investors await weight-loss drug data | RE |
01/05 | Amgen investors await weight-loss drug data | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.69% | 147B | |
+33.25% | 704B | |
+28.59% | 577B | |
-3.55% | 348B | |
+18.16% | 327B | |
+4.36% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-5.59% | 145B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- UBS Adjusts Amgen's Price Target to $257 From $248, Maintains Neutral Rating